Universidad del Valle, Guatemala
10
0
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
10.0%
1 terminated/withdrawn out of 10 trials
88.9%
+2.4% vs industry average
10%
1 trials in Phase 3/4
13%
1 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Plastic Waste and Human Health Effects in Guatemala
Role: collaborator
Household Air Pollution and Health: A Multi-country LPG Intervention Trial
Role: collaborator
Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness
Role: collaborator
Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children
Role: collaborator
Maternal Tdap Immunization in Guatemala
Role: collaborator
SMS Mobile Technology to Improve Early Childhood Vaccine Coverage in Guatemala
Role: collaborator
NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health
Role: collaborator
Panama and El Salvador Children's Oseltamivir Study
Role: collaborator
Randomised Exposure Study of Pollution Indoors and Respiratory Effects
Role: collaborator
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
Role: collaborator
All 10 trials loaded